Stefano Molica
Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic leukemia
Molica, Stefano; Allsup, David John; Polliack, Aaron
Citation
Molica, S., Allsup, D. J., & Polliack, A. (2022). Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic leukemia. Leukemia & Lymphoma, https://doi.org/10.1080/10428194.2022.2087072
| Journal Article Type | Commentary |
|---|---|
| Acceptance Date | May 30, 2022 |
| Online Publication Date | Jun 15, 2022 |
| Publication Date | 2022 |
| Deposit Date | Jun 27, 2022 |
| Publicly Available Date | Jun 16, 2023 |
| Journal | Leukemia and Lymphoma |
| Print ISSN | 1042-8194 |
| Electronic ISSN | 1029-2403 |
| Publisher | Taylor and Francis |
| Peer Reviewed | Peer Reviewed |
| DOI | https://doi.org/10.1080/10428194.2022.2087072 |
| Public URL | https://hull-repository.worktribe.com/output/4020606 |
This output contributes to the following UN Sustainable Development Goals:
Ensure healthy lives and promote well-being for all at all ages
Files
Accepted manuscript
(326 Kb)
PDF
Copyright Statement
©2022 The authors.
You might also like
Network meta-analysis of upfront fixed-duration therapies in chronic lymphocytic leukemia
(2024)
Journal Article
Epcoritamab in B-cell malignancies: current status and prospects
(2024)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search